875results about "Carbon active ingredients" patented technology

Controlled release compositions of matter are disclosed comprising complexes for treating a population of one or more aquatic organisms in a column of water. The complexes comprise at least one system wherein the system comprises at least one bioactive agent as a component selected for treating a population of aquatic organisms, at least one carrier component, and at least one coating component for regulating the controlled release rate and release profile of the bioactive agent in water or at least one bioactive agent and one joint-function component that can serve as both a carrier and coating to regulate the controlled release rate and release profile of the bioactive agent in water, with or without optional binder components and / or additional formulation materials. The components are selected to sink or float so that the complexes will permeate and / or remain in any planar or volumetric segment of a water column for a period of time that is sufficient to effectively treat a population of aquatic organisms. Methods for treating a column of water are also disclosed which comprises delivering the compositions to a column of water or to a dry preflood area (pretreatment) that will develop in a column of water or a flood area. The composition and process can also be used to treat terrestrial organisms.

The present invention provides a delivery system and method to deliver topically homeopathic amounts of at least one Homeopathic Complex. It further provides a Homeopathic Colored Pigment Product containing a coloring agent having a plurality of particles having at least one surface and a homeopathically effective amount of at least one Homeopathic Complex, wherein the at least one surface of particles in the plurality of particles of the coloring agent contains the at least one Homeopathic Complex. It also provides cosmetic formulations containing the Homeopathic Colored Pigment Product for normal skin, problem skin, aged skin, and skin damaged by the harmful rays of the sun.

The invention concerns high-performance adsorbents based on activated carbon of high meso- and macroporosity which are present in the form of discrete grains of activated carbon, whereinat least 55% of the total pore volume of the high-performance adsorbents are formed by pores (i.e. meso- and macropores) having pore diameters of more than 20 Å,the high-performance adsorbents have a measure of central tendency pore diameter of more than 25 Å, andthe high-performance adsorbents have a BET surface area of at least 1250 m2 / g.These high-performance adsorbents are obtainable by a novel process comprising specific two-stage activation, and have, in addition to the aforementioned properties, an excellent abrasion and bursting resistance, so that they are useful for a multiplicity of different applications.

An augmented synthetic resin is provided. That resin includes carbon nanotubes dispersed in a polymethylmethacrylate matrix. The method of preparing this synthetic resin includes the mixing and disaggregating of the carbon nanotubes.

The invention concerns high performance adsorbents based on activated carbon of high microporosity which are present in the form of discrete grains of activated carbon, preferably in spherical form, and which are characterized by the following parameters: a Gurvich total pore volume of at least 0.7 cm3 / g, at least 70% of this total pore volume being formed by micropores having pore diameters of ≦20 Å, a measure of central tendency pore diameter of not more than 30 Å, and a BET surface area of at least 1500 m2 / g. These high performance adsorbents are particularly useful for the adsorption of toxins, noxiants and odors, in particular from gas or to be more precise air streams, for purifying or cleaning gases, such as in particular air, for application in medicine or to be more precise pharmacy and as sorptive storage media for gases, in particular hydrogen.

The present invention is directed to compositions, products and methods useful for bone and tooth mineralization. The compositions comprise polymer microcapsules containing aqueous salt solutions. The shells of the microcapsules can be semi-permeable or impermeable. Solutions of calcium, fluoride and phosphate salts are particularly useful in the compositions of the invention. The microcapsules are preferably prepared by surfactant free inverse emulsion interfacial polymerization. Bone products include cements, scaffolds and bioactive glass. Dental products include pastes, gels, rinses and many other dental materials.

Antimicrobial activated carbon having controlled release of the antimicrobial active agent are provided comprising activated carbon and an antimicrobial coating applied to at least a portion of its exposed outer surface wherein the antimicrobial coating comprises a binder and an antimicrobial water soluble glass or an inorganic ion exchange type antimicrobial agent. The antimicrobial coatings to be applied to the activated carbon materials are curable liquids or ultra-fine thermoplastic powder coatings. The antimicrobial activated carbon materials may be employed in filters as a loose fill or in sintered filters.

The present invention is directed to a cosmetic composition comprising effective amounts of fullerene clusters in association with cosmetically acceptable carrier to prevent or retard free radical oxidation processes in the skin and to the method of using said composition for reducing damage to healthy skin or mucous membranes by free radicals.

Delivering nitric oxide to a treatment site, such as in the area of an implanted stent, over a period of hours or days is desirable; however, the storage and release of nitric oxide in medically-relevant situations and amounts is a challenge, in part due to the gaseous nature of nitric oxide and its instability in the presence of oxygen. The present invention provides a method of preparing compositions of matter, particularly those comprising nanotubules, containing nitric oxide or gases with nitric oxide-like biological activity, where the gas is non-covalently bound to the composition. These compositions allow for the storage of nitric oxide or a related gas, followed by controlled release of the gas. Compositions disclosed in the present invention include polymers, articles, pills, capsules, and medical devices.

Compositions which deliver adsorbents, alone or in combination with active drug “degrading molecules,” in a site-specific manner to the intestine, and which eliminate or at least lower the concentration of residual unwanted material within the intestine, are disclosed. Methods of treatment using the compositions are also disclosed. The material to be eliminated can include residual active antibiotics, metabolites, bacterial or other toxins, and drugs which cause side effects in the gastrointestinal tract. The adsorbents can be formulated in capsules, tablets or any acceptable pharmaceutical composition, and are ideally designed to specifically release the adsorbents in a programmed manner at a specific site of the intestinal tract. The programmed delivery prevents adsorbents from interfering with the normal absorption process of a given molecule after oral absorption, until it reaches the lower part of the small intestine. The compositions can be used to adsorb, and therefore remove, any residual drug, metabolite thereof, or bacterial toxin after oral or parenteral administration which would otherwise cause adverse effects in the lower intestine and / or colon.

Methods, systems and formulations for normalizing and improving human body chemistry and the body's natural ability to heal itself. In one embodiment a system including effective amounts of a digestive enzyme, soluble and insoluble fiber, laxative, probiotics, vitamin C, potassium, protease enzymes, lipase, lysine, taurine, proline, choline, inositol, inositol hexaphosphate, policosanol, charcoal, bentonite clay, thyme, ascorbic acid, magnesium citrate, calcium citrate, methylsulfonyl methane, cayenne pepper, magnesium, potassium, ester-c, ginger and niacin, lysine calcium, stevia leaf, citric acid, a tincture of bayberry bark, juniper berries, yam root, cramp bark, golden seal root, fennel seed, uva ursi leaves, ginger root, lobelia herb, catnip herb, and peppermint leaf, golden seal root, Echinacea angustifolia root, ginger root, and licorice root, a tincture of black walnut hulls, venus fly trap, chaparral, wormwood, licorice root, slippery elm, cloves and comfrey root, burdock root, sheep sorrel, rhubarb root, slippery elm, olive leaf and yarrow flower is provided.

A method for making the microporous carbon with modified pore size distribution and advanced sorption behaviour. The carbon is derived from metal or metalloid carbides. The method employs the use of oxidant in reaction medium that during the carbide conversion into carbon widens small micropores, which otherwise would be hardly accessed by sorbing molecules or ions in practical applications. The microporous carbon obtained is free of impurities and possesses extremely narrow pore size distribution.

A treatment tool and tissue collection system, for removal of outer layers of skin to provide a revitalized, fresh skin surface, and a method of using same, comprising a abrasive tipped tool mounted on the end or within the end of a hollow tube, said tube being connected to a source of vacuum. The vacuum aids in maintaining intimate contact between the abrasive tip and the skin during the treatment process and transports the removed tissue to a collection container. The abrasive surface within the tube is a motor driven abrasive pad. Contact between the pad and the abrasive disk is brought about or increased by application of a vacuum through the tube to the skin surface.

A method and anorectal formulation for treating a hemorrhoidal disease in a patient suffering therefrom. The method comprises the local administration of a therapeutically effective amount of activated carbon to the anorectal region of a patient. The anorectal formulation comprises a therapeutically effective amount of activated carbon as an active agent. The formulation may include one or more pharmaceutically acceptable carriers with or without one or more additional active agents. Also disclosed are methods of making the anorectal formulation and kits for treating hemorrhoidal diseases.

Nanodiamonds can be included in various compositions to take advantage of the ability of nanodiamond to bond with biological materials and to improve mechanical strength. Nanodiamonds can be dispersed in a biologically acceptable carrier to form various nanodiamond compositions. The presence of nanodiamonds can increase binding with many biological materials, making the compositions of the present invention useful for a large variety of purposes such as cleansing, testing and identification of materials, and treatment of adverse conditions. Specific examples of nanodiamond compositions that can be formulated include deodorants, toothpastes, shampoos, antibiotics, dermal strips, DNA test strips, skin cleansers, and the like. Similarly, nanodiamond particles can be included in a cosmetic nanodiamond composition within a cosmetically acceptable carrier. Cosmetic nanodiamond compositions can include, for example, nail polish, eyeliner, lip gloss, exfoliant, and the like.

The present invention is directed to a cosmetic composition comprising effective amounts of fullerene clusters in association with cosmetically acceptable carrier to prevent or retard fee radical oxidation processes in the skin and to the methods of using said composition for reducing damage to healthy skin or mucous membranes by free radicals.

A composition for in situ formation of an artificial blockage to control bleeding includes a suitable amount of a polymer-forming component, a suitable amount of a crosslinking agent, hydrogen peroxide, and a decomposing agent for hydrogen peroxide. The decomposing agent includes exogenous or endogenous catalase, or both.

The invention discloses an antibacterial anti-inflammatory composition and a preparation method and a pharmaceutical preparation thereof, belonging to the field of medical preparations. The composition is composed of natural antibiotics and graphene at the first time, wherein the natural antibiotics are selected from one or more of houttuynia cordata, pomegranate bark, common andrographis herb, astragalus, isatis root, white paeony root, honeysuckle flower, radix bupleuri, scutellaria baicalensis, radices trichosanthis, mother chrysanthemum, dandelion, folium isatidis, selfheal, radix sophorae flavescentis, purslane, rheum officinale, moutan bark, sweet wormwood, perilla leaf, liquorice, agastache rugosus, realgar, fructus forsythiae, garlic, polygonum cuspidatum, coptis chinensis, the tuber of stemona or golden cypress. According to the composition, the two components have a synergistic effect, and good antibacterial anti-inflammatory effects are achieved.

A wind turbine 10 will be used as a propulsion system for a vehicle and will keep it in motion after initial start and take off by a battery pack 14. The air and / or wind being forced on the vehicle as a result of its motion will rotate the turbine's blades 10A. The energy will cause a low-speed shaft 10B to rotate, which will in turn, cause a set of gears 10C to spin. The gears 10C will then cause a high-speed shaft 10D to rotate; this will allow the electrical generator 10E to generate electricity. The electricity generated will travel through a pair of conductive wires 12 to a set of battery packs 14. The energy will recharge the set of battery packs 14; this will allow for enough continuous energy to keep the vehicle in motion for the desired time period.

The present invention provides a novel approach to cancer therapy and diagnostics that utilizes nanotubes and other similar nanostructures as both an indirect source of radiation therapy (BNCT), and as delivery vehicles for other types of radio- and chemo-therapeutic materials, as well as imaging agents for diagnostic purposes.

The invention provides a water-soluble fullerene derivative, composite and the applications in the preparation process of medicament used for inhibiting growth and transfer of tumor; the derivative is fullerols presented by a general formula: C60OxHy; wherein, y is more than 10 and less than or equal to x; x is less than 50 and more than or equal to y; alternatively, the derivative is fullerene carboxyl derivative presented by the general formula C60(C(COOH)2)n; wherein, n is equal to 1-3; the tumor inhibiting composite comprises the grains of the water-soluble fullerene derivative and pharmaceutically acceptable carrier. The invention has the advantages that: compared with cyclophosphamide, cisplatin, paclitaxel, and the like, which are generally applied to clinic at present; the fullerols and carboxylic fullerene nano grains have small dosage, low toxicity and can inhibite the growth and transfer of the tumor.

The invention relates to a formulation for the delayed and controlled delivery of an adsorbent into the lower intestine of mammals. The formulation includes a carrageenan and an adsorbent, such as activated charcoal. The invention further relates to uses of this formulation, in particular to pharmaceutical uses. In one embodiment, the formulation is used to eliminate or reduce the side effects in the intestine, in particular in the colon, of pharmaceutical agents that are administered as a treatment for a disorder, but that have side effects when they reach the late ileum, the caecum or the colon.

Non-porous carbon materials that are materials other than a fullerene or a nanotube are employed for medical use, wherein the carbon material has a smallest dimension of less than 100 nanometer. In preferred aspects, the material is topically used on a wounds, orally administered as sorbent for various toxins, or employed as a sorbent in hemodialysis.

The invention relates to water-soluble fullerene and preparing method thereof, can effectively solve the problems of poor solubility, low photosensitive activity and poor biocompatibility of the conventional fullerene, and adopts the technical scheme that water-soluble polymer polyethylene imine is connected to a fullerene molecule through chemical bonds to obtain water-soluble fullerene; and theweight ratio of polyethylene imine to fullerene is 0.08 to 0.12 : 1. The method comprises the following steps: the fullerene is reacted with an ammoniation reagent to obtain amino fullerene; amino fullerene is reacted with aziridine in such a manner that under the existence of protonated hydrogen ions, aziridine is grafted on amino groups continuously; and finally, the polymer of fullerene and polyethylene imine (namely water-soluble fullerene) is obtained. The water-soluble fullerene prepared according to the invention has the advantages that the characteristics of fullerene are not damaged;the water dispersibility is high; the toxicity is low; the stability is favorable; the preparation method is simple; the cost is low; and the water-soluble fullerene serves as a photosensitizer or a medicine carrier during the preparation of medicines curing cancers.

A method of fabricating a porous carbon composition, the method comprising subjecting a precursor composition to a thermal annealing step followed by a carbonization step, the precursor composition comprising: (i) a templating component comprised of a block copolymer and (ii) a lignin component, wherein said carbonization step comprises heating the precursor composition at a carbonizing temperature for sufficient time to convert the precursor composition to a carbon material comprising a carbon structure in which is included mesopores having a diameter within a range of 2 to 50 nm, wherein said porous carbon composition possesses a mesopore volume of at least 50% with respect to a total of mesopore and micropore volumes. Also described are the resulting mesoporous carbon composition, a composite of the mesoporous carbon material and at least one pharmaceutical agent, and the administration of the carbon-pharmaceutical dosage form to a subject.

According to an aspect of the invention, injectable bulking compositions are provided which contain the following: (a) fibers that are configured to prevent migration to locations in the body remote from the injection site, for example, because they have a minimum length that is sufficiently large to prevent migration of the fibers and / or because they have surface features that stimulate host tissue response to lock the fibers in position and (b) a carrier in an amount effective to render the composition injectable.

A microcapsule composition comprising at least one polymer substantially disposed as a semi-permeable shell around an aqueous buffered solution and at least one agent, wherein the agent permeates the shell, and wherein the composition is suitable for delivery to a mammal. This invention also provides related compositions, products and methods.

A method for producing biochar particles or pellets which use sulphur and other additives. The method includes producing a mixture with biochar and additives selected from sulphur, lignin, and gluten. The mixture is mixed with water and passed through an extruder to produce an extrudate. The extrudate is then cut into pellets. The pellets are then tumbled / spun with each other and heated to result in mostly spheroidal pellets whose mechanical characteristics allow them to be used with well-known agricultural equipment. The biochar can be produced with sulphur incorporated as an outer coating. To produce this sulphur coated biochar, the method includes feeding a biomass feedstock to a pyrolysis reactor, pyrolyzing the feedstock into biochar particles, size-sorting the biochar particles, and coating the biochar particles with the sulphur coating material.